EPISODE · Oct 10, 2023 · 2 MIN
Immunotherapy for Patients with Resectable NSCLC and a Driver Mutation
from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE
Dr. Joshua Reuss explains why immunotherapy is not typically given to patients with resectable NSCLC and a driver mutation.
Embed this episode
NOW PLAYING
Immunotherapy for Patients with Resectable NSCLC and a Driver Mutation
0:00
2:05
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?
This episode is 2 minutes long.
When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?
This episode was published on October 10, 2023.
Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!